WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS

Clinical trials for WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS explained in plain language.

Never miss a new study

Get alerted when new WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS trials appear

Sign up with your email to follow new studies for WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Formula for safer pregnancies after uterus transplant

Disease control Not yet recruiting

This study aims to create a better formula for adjusting a key anti-rejection medication (tacrolimus) during pregnancy. It will involve about 55 women who have received a uterus transplant. The goal is to more accurately measure the active drug in the blood to help maintain a hea…

Matched conditions: WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS

Sponsor: Baylor Research Institute • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS

Get alerted when new WHOLE BLOOD TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS trials appear

Formula for safer pregnancies after uterus transplant